High frequency of the H63D mutation of the hemochromatosis gene (HFE) in malignant gliomas
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Risk factors for brain tumors, except for ionizing radiations, remain substantially unknown.1 Iron exposure could be among these factors, as in vitro iron may promote the growth of malignant gliomas2 and iron chelators can inhibit this growth.3 Excess iron can favor the generation of highly reactive hydroxyl radicals, which, in turn, may cause point mutations in genomic DNA. Furthermore, increased levels of non-heme iron can convert nitric oxide from a proapoptotic to an antiapoptotic molecule. Notably, the c-myc oncogene, which is also expressed in high-grade gliomas, modulates the expression of genes controlling iron homeostasis, increasing the availability of intracellular iron.4
The hereditary hemochromatosis gene (HFE) has a critical role in iron homeostasis and two mutations of this gene, C282Y and H63D, are …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Deborah Friedman and Dr. Stacy Smith
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Brief Communications
The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1J. R. Leonard, A. Perry, J. B. Rubin et al.Neurology, October 23, 2006 -
Clinical Implications of Neuroscience Research
Brain iron homeostasis and neurodegenerative diseaseEduardo E. Benarroch et al.Neurology, April 20, 2009 -
ARTICLES
The prognostic impact of prior low grade histology in patients with anaplastic gliomasA case-control studyEdward J. Dropcho, Seng-jaw Soong et al.Neurology, September 01, 1996 -
Articles
Altered systemic iron metabolism in Parkinson's diseaseG. Logroscino, K. Marder, J. Graziano et al.Neurology, September 01, 1997